|
1
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee: Heart disease and stroke statistics - 2014
update: A report from the American Heart Association. Circulation.
129:399–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dawber TR, Moore FE and Mann GV: Coronary
heart disease in the Framingham study. Am J Public Health Nations
Health. 47:4–24. 1957. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sivapalaratnam S, Boekholdt SM, Trip MD,
Sandhu MS, Luben R, Kastelein JJ, Wareham NJ and Khaw KT: Family
history of premature coronary heart disease and risk prediction in
the EPIC-Norfolk prospective population study. Heart. 96:1985–1989.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bolland MJ, Avenell A, Baron JA, Grey A,
MacLennan GS, Gamble GD and Reid IR: Effect of calcium supplements
on risk of myocardial infarction and cardiovascular events:
Meta-analysis. BMJ. 341:c36912010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Canto JG, Kiefe CI, Rogers WJ, Peterson
ED, Frederick PD, French WJ, Gibson CM, Pollack CV Jr, Ornato JP,
Zalenski RJ, et al: NRMI Investigators: Number of coronary heart
disease risk factors and mortality in patients with first
myocardial infarction. JAMA. 306:2120–2127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Horne BD, Camp NJ, Muhlestein JB and
Cannon-Albright LA: Identification of excess clustering of coronary
heart diseases among extended pedigrees in a genealogical
population database. Am Heart J. 152:305–311. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hartiala J, Schwartzman WS, Gabbay J,
Ghazalpour A, Bennett BJ and Allayee H: The genetic architecture of
coronary artery disease: Current knowledge and future
opportunities. Curr Atheroscler Rep. 19:62017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Assmann G, Cullen P and Schulte H: Simple
scoring scheme for calculating the risk of acute coronary events
based on the 10-year follow-up of the prospective cardiovascular
Münster (PROCAM) study. Circulation. 105:310–315. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gyárfás I, Keltai M and Salim Y: Effect of
potentially modifiable risk factors associated with myocardial
infarction in 52 countries in a case-control study based on the
INTERHEART study. Orv Hetil. 147:675–686. 2006.(In Hungarian).
PubMed/NCBI
|
|
10
|
Basat O, Ucak S, Seber S, Oztekin E and
Altuntas Y: After myocardial infarction carvedilol improves insulin
resistance compared to metoprolol. Clin Res Cardiol. 95:99–104.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tölg R, Witt M, Schwarz B, Kurz T,
Kurowski V, Hartmann F, Geist V and Richardt G: Comparison of
carvedilol and metoprolol in patients with acute myocardial
infarction undergoing primary coronary intervention - the PASSAT
Study. Clin Res Cardiol. 95:31–41. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ilic Deljanin M, Pavlovic RF, Kocic G,
Simonovic D and Lazarevic G: Effects of music therapy on
endothelial function in patients with coronary artery disease
participating in aerobic exercise therapy. Altern Ther Health Med.
23:at54912017.PubMed/NCBI
|
|
13
|
Cai X, Bao L, Ding Y, Dai X, Zhang Z and
Li Y: Quercetin alleviates cell apoptosis and inflammation via the
ER stress pathway in vascular endothelial cells cultured in high
concentrations of glucosamine. Mol Med Rep. 15:825–832. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bischoff B, Silber S, Richartz BM, Pieper
L, Klotsche J and Wittchen HU: DETECT Study-Group: Inadequate
medical treatment of patients with coronary artery disease by
primary care physicians in Germany. Clin Res Cardiol. 95:405–412.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Koch KC, Schaefer WM, Liehn EA, Rammos C,
Mueller D, Schroeder J, Dimassi T, Stopinski T and Weber C: Effect
of catheter-based transendocardial delivery of stromal cell-derived
factor 1alpha on left ventricular function and perfusion in a
porcine model of myocardial infarction. Basic Res Cardiol.
101:69–77. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Looi KL, Chow KL, Looi JL, Lee M, Halliday
S, White H and Ellis C: Under-use of secondary prevention
medication in acute coronary syndrome patients treated with
in-hospital coronary artery bypass graft surgery. N Z Med J.
124:18–27. 2011.PubMed/NCBI
|
|
17
|
Costalunga A and Gavazzi A: Effect of
carvedilol on outcome after myocardial infarction in patients with
left ventricular dysfunction: The CAPRICORN randomized trial. Ital
Heart J Suppl. 2:1246–1247. 2001.(In Italian). PubMed/NCBI
|
|
18
|
Gunnar RM, Bourdillon PD, Dixon DW, Fuster
V, Karp RB, Kennedy JW, Klocke FJ, Passamani ER, Pitt B, Rapaport
E, et al: ACC/AHA guidelines for the early management of patients
with acute myocardial infarction. A report of the American College
of Cardiology/American Heart Association Task Force on Assessment
of Diagnostic and Therapeutic Cardiovascular Procedures
(subcommittee to develop guidelines for the early management of
patients with acute myocardial infarction). Circulation.
82:664–707. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gislason GH, Rasmussen JN, Abildstrøm SZ,
Gadsbøll N, Buch P, Friberg J, Rasmussen S, Køber L, Stender S,
Madsen M, et al: Long-term compliance with beta-blockers,
angiotensin-converting enzyme inhibitors, and statins after acute
myocardial infarction. Eur Heart J. 27:1153–1158. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rochon PA and Gurwitz JH: Prescribing for
seniors: Neither too much nor too little. JAMA. 282:113–115. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ruta J, Ptaszyński P, Maciejewski M, Goch
JH and Chizyński K: Effect of low doses of metoprolol, bisoprolol
and carvedilol on mortality in patients with left ventricular
dysfunction after acute myocardial infarction. Wiad Lek.
59:649–653. 2006.(In Polish). PubMed/NCBI
|
|
22
|
Grall S, Biere L, Le Nezet M, Bouvier JM,
Lucas-Chauvelon P, Richard C, Abi-Khalil W, Delepine S, Prunier F
and Furber A: Relationship between beta-blocker and
angiotensin-converting enzyme inhibitor dose and clinical outcome
following acute myocardial infarction. Circ J. 79:632–640. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Siu CW, Pong V, Jim MH, Yue WS, Ho HH, Li
SW, Lau CP and Tse HF: Beta-blocker in post-myocardial infarct
survivors with preserved left ventricular systolic function. Pacing
Clin Electrophysiol. 33:675–680. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goldberger JJ, Bonow RO, Cuffe M, Liu L,
Rosenberg Y, Shah PK, Smith SC Jr and Subačius H: OBTAIN
Investigators: Effect of beta-blocker dose on survival after acute
myocardial infarction. J Am Coll Cardiol. 66:1431–1441. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miyauchi Y, Zhou S, Okuyama Y, Miyauchi M,
Hayashi H, Hamabe A, Fishbein MC, Mandel WJ, Chen LS, Chen PS, et
al: Altered atrial electrical restitution and heterogeneous
sympathetic hyperinnervation in hearts with chronic left
ventricular myocardial infarction: Implications for atrial
fibrillation. Circulation. 108:360–366. 2003. View Article : Google Scholar : PubMed/NCBI
|
